CSMF
AGN

Charles Stewart Mott Foundation’s Allergan plc AGN Stock Holding History

Charles Stewart Mott Foundation’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,642
Closed -$446K – 88
2015
Q3 		$446K Buy
+1,642
New +$504K 0.5% 36

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Charles Stewart Mott Foundation's AGN Position: Q4 2015 in Review

Charles Stewart Mott Foundation sold out of Allergan plc (AGN) in Q4 2015, closing a stake of 1,642 shares — an estimated $446K sold.

Charles Stewart Mott Foundation first reported a position in AGN in Q3 2015 and held it in 1 quarter. The position peaked at $446K in Q3 2015. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

  • Charles Stewart Mott Foundation reported no remaining Allergan plc position as of Q4 2015 after selling out during the quarter.
  • Charles Stewart Mott Foundation sold 1,642 Allergan plc shares in Q4 2015, an estimated $446K.
  • Charles Stewart Mott Foundation first reported a position in Allergan plc in Q3 2015 and held it in 1 quarter.
  • Charles Stewart Mott Foundation's Allergan plc position peaked at $446K in Q3 2015.
  • 1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Charles Stewart Mott Foundation's 13F filing for Q4 2015, filed 16 Feb 2016.